Fulgent Genetics COO sells 2,127 shares for taxes

Fulgent Genetics’ President and COO sold shares mainly to cover tax withholding from RSU vesting and continues to hold substantial direct and trust-related positions.

Rhea-AI Filing Summary

Fulgent Genetics, Inc. (FLGT) reports that President and COO Jian Xie sold 2,127 shares of common stock on September 2, 2026 at a weighted-average price of $19.6564 per share to satisfy tax withholding obligations arising from vesting of previously granted restricted stock units. Following this sale, he directly holds 359,924 shares and has indirect ownership of 220,816 shares held by The Hsieh Family Dynasty Trust, where he serves on the investment committee and disclaims beneficial interest except for any pecuniary interest. No Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

Net Seller: 2,127 shares

Net Sell 2 txns

Insider Xie Jian

Role President and COO

Sold 2,127 shs ($42K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	2,127	$19.6564	$42K
holding	Common Stock F3	--	--	--

Holdings After Transaction: Common Stock — 359,924 shares (Direct); Common Stock — 220,816 shares (Indirect, By Trust)

Footnotes (3)

1. F1. The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.
2. F2. The shares were sold in multiple transactions at prices ranging from $19.60 to $19.74, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
3. F3. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.

Key Figures

Shares sold: 2,127 shares Weighted-average sale price: $19.6564 per share Direct holdings after transaction: 359,924 shares +4 more

7 metrics

Shares sold 2,127 shares Common stock sale on September 2, 2026

Weighted-average sale price $19.6564 per share Sale of 2,127 shares in multiple transactions between $19.60 and $19.74

Direct holdings after transaction 359,924 shares Common stock directly held by Jian Xie following the sale

Indirect holdings by Trust 220,816 shares Common stock held by The Hsieh Family Dynasty Trust, with pecuniary interest to Jian Xie

RSU grant date February 25, 2025 Restricted stock units whose vesting triggered the tax withholding sale

Form 4 prior report date February 27, 2025 Date the original RSU grant was reported

Sale price range $19.60–$19.74 per share Range of prices for the multiple sale transactions on September 2, 2026

Key Terms

restricted stock units, weighted-average sale price, pecuniary interest, indirect ownership

4 terms

restricted stock units financial

"tax withholding obligations that arose upon the vesting of certain restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted-average sale price financial

"The reported price reflects the weighted-average sale price."

pecuniary interest financial

"Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein."

indirect ownership financial

"Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010"

FAQ

What insider transaction did FLGT report for President and COO Jian Xie?

Fulgent Genetics reported that Jian Xie sold 2,127 shares of common stock on September 2, 2026 at a weighted-average price of $19.6564 per share, described as a sale to satisfy tax withholding obligations from vesting restricted stock units.

Why did the FLGT insider sell 2,127 shares on September 2, 2026?

The filing states the 2,127 shares were sold by Jian Xie to satisfy tax withholding obligations that arose upon vesting of restricted stock units granted on February 25, 2025 and previously reported on a Form 4 filed on February 27, 2025.

What price did the FLGT insider receive for the sold shares?

The shares were sold in multiple transactions at prices ranging from $19.60 to $19.74 per share. The reported figure of $19.6564 per share is a weighted-average sale price for the 2,127 shares sold.

How many FLGT shares does Jian Xie hold after the reported sale?

After the September 2, 2026 sale, Jian Xie directly holds 359,924 shares of Fulgent Genetics common stock. In addition, 220,816 shares are held indirectly through The Hsieh Family Dynasty Trust, where he has a pecuniary interest but disclaims other beneficial ownership.

Were the FLGT insider trades made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that no Rule 10b5-1 plan is reported for these transactions, and the footnotes describe the sale as being for tax withholding obligations related to restricted stock unit vesting.

What is the nature of Jian Xie’s indirect ownership of FLGT shares?

The filing reports 220,816 shares held by The Hsieh Family Dynasty Trust. Jian Xie serves on the trust’s investment committee and disclaims beneficial interest in those shares except with respect to any pecuniary interest he may have.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 07:48 PM Accepted by SEC EDGAR 09/03/2026 - 07:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Xie Jian

(Last) (First) (Middle)

C/O FULGENT GENETICS, INC.

4399 SANTA ANITA AVENUE

(Street)

EL MONTE CALIFORNIA 91731

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Fulgent Genetics, Inc. [ FLGT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2026		S		2,127(1)	D	$19.6564(2)	359,924	D
Common Stock								220,816	I	By Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.

2. The shares were sold in multiple transactions at prices ranging from $19.60 to $19.74, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

3. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.

	/s/ Paul Kim as Attorney-in-Fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)